2011Journal of Medical ForumRequires access

Clinical significance and expression of Ezrin and bcl-2 in gastric carcinoma

Guorong Zheng

Open publisher page 0 citations

Abstract

Objective To explore the expression of ezrin and bcl-2 in gastric carcinoma and analyze the relationship between their expression and clinicopathological characteristics.Methods A series of 58 gastric carcinomas,20 normal gastric mucosal samples were examined for the expression of Ezrin and bcl-2 using immunohistochemistry.The correlation and clinical significance were analyzed.Results The positive rates of Ezrin protein were 25.0 %(5/20),63.9%(37/58)in normal gastric tissues and gastric carcinoma,and that of bcl-2 protein were 30%(6/20)and 65.5%(38/58),respectively.The expression of Ezrin was correlated to the clinical stage and lymph nodemetastasis,while the expression of bcl-2 was correlated to the clinical stage.The expression of ezrin was positively correlated to that of bcl-2 in gastric carcinoma(rp=0.785).Conclusions The expression rate of ezrin and bcl-2 were higher in gastric carcinoma.They may play an important role in the development of gastric carcinoma.Further analysis on the pathways downstream of ezrin are warranted.

About this research paper

What this paper is about

Objective To explore the expression of ezrin and bcl-2 in gastric carcinoma and analyze the relationship between their expression and clinicopathological characteristics.Methods A series of 58 gastric carcinomas,20 normal gastric mucosal samples were examined for the expression of Ezrin and bcl-2 using immunohistochemistry.The correlation and clinical significance were analyzed.Results The positive rates of Ezrin protein were 25.0 %(5/20),63.9%(37/58)in normal gastric tissues and gastric carcinoma,and that of bcl-2 protein were 30%(6/20)and 65.5%(38/58),respectively.The expression of Ezrin was correlated to the clinical stage and lymph nodemetastasis,while the expression of bcl-2 was correlated to the clinical stage.The expression of ezrin was positively correlated to that of bcl-2 in gastric carcinoma(rp=0.785).Conclusions The expression rate of ezrin and bcl-2 were higher in gastric carcinoma.They may play an important role in the development of gastric carcinoma.Further analysis on the pathways downstream of ezrin are warranted.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To explore the expression of ezrin and bcl-2 in gastric carcinoma and analyze the relationship between their expression and clinicopathological characteristics.Methods A series of 58 gastric carcinomas,20 normal gastric mucosal samples were examined for the expression of Ezrin and bcl-2 using immunohistochemistry.The correlation and clinical significance were analyzed.Results The positive rates of Ezrin protein were 25.0 %(5/20),63.9%(37/58)in normal gastric tissues and gastric carcinoma,and that of bcl-2 protein were 30%(6/20)and 65.5%(38/58),respectively.The expression of Ezrin was correlated to the clinical stage and lymph nodemetastasis,while the expression of bcl-2 was correlated to the clinical stage.The expression of ezrin was positively correlated to that of bcl-2 in gastric carcinoma(rp=0.785).Conclusions The expression rate of ezrin and bcl-2 were higher in gastric carcinoma.They may play an important role in the development of gastric carcinoma.Further analysis on the pathways downstream of ezrin are warranted.

Key concepts: Ezrin, Gastric carcinoma, Immunohistochemistry, Clinical significance, Carcinoma, Medicine, Stage (stratigraphy), Cancer research

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical significance and expression of Ezrin and bcl-2 in gastric carcinoma — Research Paper | ScholarLens